Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis (Q28143909)
Jump to navigation
Jump to search
scientific article (publication date: 2000)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis |
scientific article (publication date: 2000) |
Statements
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis (English)
van Stolk R
Stoner G
Hayton WL
Chan K
DeYoung B
Kresty L
Kemmenoe BH
Elson P
Rybicki L
Church J
Provencher K
McLain D
Hawk E
Fryer B
Kelloff G
Ganapathi R
1 January 2000
Identifiers
2 references